Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina (ILMN) Reports Q2 Earnings: What Key Metrics Have to Say
08:31pm, Thursday, 30'th Jul 2026
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Illumina, Inc. (ILMN) Q2 2026 Earnings Call Transcript
07:53pm, Thursday, 30'th Jul 2026
Illumina, Inc. (ILMN) Q2 2026 Earnings Call Transcript
Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates
07:00pm, Thursday, 30'th Jul 2026
Illumina (ILMN) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.19 per share a year ago.
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
04:05pm, Thursday, 30'th Jul 2026
SAN DIEGO, July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 20
Insights Into Illumina (ILMN) Q2: Wall Street Projections for Key Metrics
10:16am, Wednesday, 29'th Jul 2026
Get a deeper insight into the potential performance of Illumina (ILMN) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Sale of Mass Cytometry Business to Multiplex Bio Ensures Full Continuity of CyTOF and Hyperion Product Lines, Customer Relationships, Dedicated Team and Continued Investment in Next Generation Multipl
EXEL vs. ILMN: Which Stock Is the Better Value Option?
12:41pm, Friday, 24'th Jul 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Illumina (ILMN). But which of these two stocks is more attractive to value inves
Fishbone Advisors Survey: Institutional Investors See Healthcare's AI Story as Overblown
06:00am, Wednesday, 22'nd Jul 2026
CHICAGO--(BUSINESS WIRE)---- $ILMN #AI--Fishbone Advisors, a capital markets intelligence firm, today released a new report showing that healthcare's AI narrative has a credibility problem with instit
Amova Asset Management Americas Inc. Sells 165,333 Shares of Illumina, Inc. $ILMN
04:21am, Tuesday, 21'st Jul 2026
Amova Asset Management Americas Inc. trimmed its position in Illumina, Inc. (NASDAQ: ILMN) by 18.6% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund ow
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
11:51am, Monday, 20'th Jul 2026
Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.
Illumina expands Billion Cell Atlas program with new AI drug developers
12:00pm, Thursday, 16'th Jul 2026
Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO, July 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell At
Here's Why Illumina (ILMN) is a Strong Growth Stock
10:46am, Thursday, 16'th Jul 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
04:05pm, Thursday, 09'th Jul 2026
SAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026. O
Stocks Look Shaky, But This Sector is Booming (Biotech)
02:06pm, Thursday, 09'th Jul 2026
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.
Illumina (ILMN) Is Up 6.87% in One Week: What You Should Know
01:01pm, Thursday, 09'th Jul 2026
Does Illumina (ILMN) have what it takes to be a top stock pick for momentum investors? Let's find out.
